This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Atrial natriuretic peptide

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Atrial natriuretic peptide is released by myocytes in response to atrial stretch. There are a variety of forms; the originals isolated from the brain were smaller than the forms subsequently isolated from human heart.

Actions:

  • reduction of ADH-induced water reabsorption in the collecting ducts
  • relaxation of renal arterioles
  • modulatory effects of the GFR
  • inhibition of aldosterone mediated sodium reabsorption in the distal tubule (natiuretic effect)

There is massive atrial natriuretic peptide activity in end stage renal failure and congestive cardiac failure.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.